Recommandations en Psychiatrie
49 recommandations en vigueur en Psychiatrie émanant d’agences nationales, de sociétés savantes européennes et d’organismes d’HTA, réparties sur 15 groupes de sources. eUvidence ancre ses réponses en Psychiatrie sur ces recommandations ; chaque entrée renvoie à la page de l’organisme émetteur.
Sociétés savantes européennes· 8
- Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders
WHO · World Health Organization · 2023
- WFSBP Guidelines for Biological Treatment of Schizophrenia, Part 3: Update 2015 — Management of Special Circumstances: Depression, Suicidality, Substance Use Disorders and Pregnancy and Lactation
WFSBP · World Federation of Societies of Biological Psychiatry · 2015
- WFSBP Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the Long-term Treatment of Schizophrenia and Management of Antipsychotic-induced Side Effects
WFSBP · World Federation of Societies of Biological Psychiatry · 2013
- WFSBP Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the Acute and Continuation Treatment of Unipolar Depressive Disorders
WFSBP · World Federation of Societies of Biological Psychiatry · 2013
- WFSBP Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the Acute Treatment of Schizophrenia and the Management of Treatment Resistance
WFSBP · World Federation of Societies of Biological Psychiatry · 2012
- The European Psychiatric Association (EPA) Guidance on Suicide Treatment and Prevention
EPA · European Psychiatric Association · 2012
- WFSBP Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the Treatment of Acute Bipolar Depression
WFSBP · World Federation of Societies of Biological Psychiatry · 2010
- WFSBP Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania
WFSBP · World Federation of Societies of Biological Psychiatry · 2009
Belgique· 1
- Management of major depression: pharmacotherapy and psychotherapy
KCE · Belgian Health Care Knowledge Centre · 2014
Danemark· 4
- National Clinical Recommendation on Non-pharmacological Treatment of ADHD in Adults
SST · Danish Health Authority · 2025 · recommendation
- National Clinical Recommendation on Combination Treatment with Antipsychotics and ADHD Medication in Patients with Primary Psychotic Disorder
SST · Danish Health Authority · 2024 · recommendation
- National Clinical Recommendation on the Use of Sedative Medicines for Short-term Symptom Relief of New-onset Anxiety and Agitation in Adults
SST · Danish Health Authority · 2023 · recommendation
- National Clinical Guideline for the Treatment of Anxiety Disorders in Adults
SST · Danish Health Authority · 2021
Finlande· 4
- Schizophrenia
Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Psychiatric Association · 2024
- Schizophrenia
Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Psychiatric Association · 2020
- Anxiety Disorders
Kaypa hoito · Finnish Medical Society Duodecim, the Finnish Psychiatric Association and the Finnish Association of Adolescent Psychiatry · 2018
- Alcohol Abuse
Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Society of Addiction Medicine · 2015
France· 4
- Neurodevelopmental Disorder / ADHD: Diagnosis and Therapeutic Interventions in Children and Adolescents
HAS · Haute Autorité de Santé · 2024 · recommendation
- Autism Spectrum Disorder: Interventions and Life Pathway of Adults
HAS · Haute Autorité de Santé · 2018 · good practice guide
- Management of a Characterised Depressive Episode in Adults in Primary Care
HAS · Haute Autorité de Santé · 2017 · recommendation
- Patient with a Bipolar Disorder: Detection and Initial Management in Primary Care
HAS · Haute Autorité de Santé · 2015 · recommendation
Allemagne· 5
- S3 Guideline Schizophrenia
DGPPN · Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde · 2025
- National Care Guideline Unipolar Depression
DGPPN · Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde · 2022
- S3 Guideline Obsessive-Compulsive Disorders
DGPPN · Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde · 2022
- S3 Guideline Treatment of Anxiety Disorders
DGPPN · Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde · 2021
- S3 Guideline for Diagnosis and Treatment of Bipolar Disorders
DGPPN · Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde / Deutsche Gesellschaft für Bipolare Störungen · 2019
Irlande· 2
- Appropriate Prescribing of Psychotropic Medication for Non-Cognitive Symptoms in People with Dementia: National Clinical Guideline No. 21
NCEC · National Clinical Effectiveness Committee, Department of Health · 2019
- Appropriate Prescribing of Psychotropic Medication for Non-Cognitive Symptoms in People with Dementia — National Clinical Guideline No. 21
NCEC · National Clinical Effectiveness Committee, Department of Health · 2019
Italie· 1
- Diagnosis and Treatment of Adults with Autism Spectrum Disorder
ISS · Istituto Superiore di Sanita · 2023
Pays-Bas· 4
- Care Standard Bipolar Disorders
GGZ Standaarden · GGZ Standaarden (Akwa GGZ) · 2023
- Care Standard Depressive Disorders
GGZ Standaarden · GGZ Standaarden (Akwa GGZ) · 2018
- Care Standard Psychosis
GGZ Standaarden · GGZ Standaarden (Akwa GGZ) · 2017
- Care Standard Anxiety Complaints and Anxiety Disorders
GGZ Standaarden · GGZ Standaarden (Akwa GGZ) · 2017
Norvège· 2
- National clinical guideline for the treatment of psychotic disorders - drug treatment
Hdir · Norwegian Directorate of Health · 2026
- National Clinical Guideline for Medication Treatment of Psychotic Disorders
Helsedir · Norwegian Directorate of Health · 2025
Pologne· 1
- Recommendations for the Treatment of Schizophrenia with Negative Symptoms - Pharmacotherapy Standards of the Polish Psychiatric Association, Part 1
PTP · Polskie Towarzystwo Psychiatryczne · 2019 · recommendation
Portugal· 1
- Pharmacological Treatment of Major Depression and its Recurrence in Adults
DGS · Direcao-Geral da Saude · 2012
Espagne· 2
- Clinical Practice Guideline for the Treatment of Generalised Anxiety Disorder in Primary Care
GuiaSalud · Servicio de Evaluacion del Servicio Canario de la Salud / Ministerio de Sanidad · 2024
- Clinical Practice Guideline on the Management of Depression in Adults
GuiaSalud · Agencia de Conocimiento en Salud (Avalia-t) / Ministerio de Sanidad · 2023
Suède· 2
- National Guidelines for Care of Depression and Anxiety Disorders - Support for Governance and Management
Socialstyrelsen · National Board of Health and Welfare · 2021
- National Guidelines for Care and Support in Schizophrenia and Schizophrenia-like Conditions - Support for Governance and Management
Socialstyrelsen · National Board of Health and Welfare · 2018
Royaume-Uni· 8
- Depression in Adults: Treatment and Management
NICE · National Institute for Health and Care Excellence · 2022
- Post-traumatic Stress Disorder
NICE · National Institute for Health and Care Excellence · 2018
- Eating Disorders: Recognition and Treatment
NICE · National Institute for Health and Care Excellence · 2017
- Psychosis and Schizophrenia in Adults: Prevention and Management
NICE · National Institute for Health and Care Excellence · 2014
- Bipolar Disorder: Assessment and Management
NICE · National Institute for Health and Care Excellence · 2014
- Generalised Anxiety Disorder and Panic Disorder in Adults: Management
NICE · National Institute for Health and Care Excellence · 2011
- Drug Misuse in Over 16s: Psychosocial Interventions
NICE · National Institute for Health and Care Excellence · 2007
- Drug Misuse in Over 16s: Opioid Detoxification
NICE · National Institute for Health and Care Excellence · 2007
Vous cherchez un pays en particulier ? Belgique, Danemark, Finlande, France, Allemagne, Irlande.